Zydus Lifesciences Receives Demand Order Regarding Input Tax Credit

Zydus Healthcare Limited (ZHL), a subsidiary of Zydus Lifesciences, has received a demand order related to dis-allowed Input Tax Credit (ITC) and short payment of tax under Reverse Charge Mechanism (RCM). The demand pertains to financial years April 2018 to March 2023. Zydus intends to challenge the order.

Demand Order Details

Zydus Healthcare Limited (ZHL) has received a demand order pertaining to dis-allowed Input Tax Credit (ITC) and short payment of tax under Reverse Charge Mechanism (RCM) for the financial years April 2018 to March 2023.

Key Aspects of the Demand

The demand order was issued by the Assistant Commissioner of CGST, Cuttack-I Division, Odisha. The specifics involve:

  • Dis-allowed ITC and short payment of tax under RCM: Amounting to ₹2.17 million, plus applicable interest, and a penalty of ₹2.17 million.

The company received the order on October 16, 2025, at 12.06 p.m.

Company’s Response

ZHL intends to challenge the Order by filing an appeal, with the company stating that there is no material financial impact on ZHL or the Company.

Source: BSE

Previous Article

Muthoot Finance Issues USD 150 Million Senior Secured Notes

Next Article

Zen Technologies Completes 100% Acquisition of Applied Research International

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *